5
Amzel Ltd
509356 BSE
Amzel Ltd
BSE: 509356
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Amzel Ltd insights
28 extracted metrics + investor summaries across FY07–FY19.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
2- Company has low interest coverage ratio.
- Company has a low return on equity of -3.90% over last 3 years.
Growth Rate
Revenue Growth
-77.00% →
Net Income Growth
29.00% →
Cash Flow Change
-
ROE
-4.00% ↘
ROCE
-
EBITDA Margin (Avg.)
-
Quarterly Results
| Sep 2024 | Sep 2025 | |
|---|---|---|
| Sales | 254 | 294 |
| Expenses | 249 | 289 |
| Operating Profit | 5 | 6 |
| OPM % | 2% | 2% |
| Other Income | 4 | 0 |
| Interest | 0 | 0 |
| Depreciation | 0 | 0 |
| PBT | 9 | 6 |
| Tax % | 26% | 26% |
| Net Profit | 7 | 4 |
| EPS in Rs | 12.39 | 2.69 |
Profit & Loss
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 22 | 21.38 | 1.31 | 0.58 | 0.34 | 0.09 | 0 | 0 | 0.01 | 0.01 | 0.13 | 0.03 |
| Expenses | 21.36 | 21.25 | 2.25 | 2.13 | 0.99 | 0.67 | 0.99 | 0.18 | 0.28 | 0.81 | 0.17 | 0.09 |
| Operating Profit | 0.64 | 0.13 | -0.94 | -1.55 | -0.65 | -0.58 | -0.99 | -0.18 | -0.27 | -0.8 | -0.04 | -0.06 |
| OPM % | 2.91% | 0.61% | -71.76% | -267.24% | -191.18% | -644.44% | — | — | -2700% | -8000% | -30.77% | -200% |
| Other Income | 0.33 | 1.33 | 1.14 | 2.24 | 1.1 | 1.05 | 0.55 | 0.14 | 0.12 | 1.47 | 0 | 0 |
| Interest | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 |
| Depreciation | 0.09 | 0.09 | 0.07 | 0.03 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 |
| PBT | 0.87 | 1.36 | 0.13 | 0.66 | 0.45 | 0.47 | -0.44 | -0.04 | -0.16 | 0.65 | -0.04 | -0.06 |
| Tax % | 20.69% | 43.38% | 46.15% | 12.12% | 13.33% | 29.79% | -27.27% | -25% | -31.25% | 23.08% | 75% | -33.33% |
| Net Profit | 0.69 | 0.77 | 0.07 | 0.58 | 0.39 | 0.33 | -0.32 | -0.04 | -0.11 | 0.5 | -0.07 | -0.05 |
| Div. Payout % | 79.71% | 212.99% | 292.86% | 53.45% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.55 | 0.41 | 0.41 | 0.31 | 0.24 | 0.24 | 0.2 | 0.2 | 0.2 | 0.15 | 0.11 | 0.11 |
| Reserves | 5.95 | 3.63 | 3.46 | 2.84 | 2.62 | 2.96 | 2.05 | 2.01 | 1.87 | 1.44 | 1.05 | 1 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0.05 |
| Other Liabilities | 1.73 | 3.19 | 0.85 | 0.64 | 0.55 | 0.35 | 0.05 | 0.05 | 0.03 | 0.21 | 0.05 | 0.05 |
| Total Liabilities | 8.23 | 7.23 | 4.72 | 3.79 | 3.41 | 3.55 | 2.3 | 2.26 | 2.1 | 1.8 | 1.26 | 1.21 |
| Fixed Assets | 0.61 | 0.51 | 0.39 | 0.17 | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.2 | 3.19 | 3.55 | 2.88 | 2.24 | 1.95 | 1.68 | 1.69 | 0.88 | 1.1 | 0.76 | 0.68 |
| Other Assets | 7.42 | 3.53 | 0.78 | 0.74 | 1.14 | 1.57 | 0.6 | 0.55 | 1.21 | 0.7 | 0.5 | 0.53 |
| Total Assets | 8.23 | 7.23 | 4.72 | 3.79 | 3.41 | 3.55 | 2.3 | 2.26 | 2.1 | 1.8 | 1.26 | 1.21 |
Cash Flow
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1.55 | 3.43 | -0.77 | -0.73 | — | — | — | — | — | 0 | -0.13 | -0.03 |
| Investing | 1.7 | -2.36 | 0.34 | 2.01 | — | — | — | — | — | 0 | 0.22 | 0.03 |
| Financing | -1.31 | -1.31 | -1.92 | -1.18 | — | — | — | — | — | 0 | -0.24 | 0 |
| Net Cash Flow | 1.94 | -0.24 | -2.35 | 0.1 | — | — | — | — | — | 0 | -0.15 | 0 |
| Free Cash Flow | 1.32 | 3.94 | -0.31 | 0.47 | — | — | — | — | — | 0 | -0.13 | -0.03 |
| CFO/OP | 286 | 2,915 | 55 | 49 | — | — | — | — | — | 0 | 50 | 50 |
Ratios
| Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 12.61 | 6.66 | 25.08 | 18.88 | 10.74 | 0 | — | — | 0 | 0 | 0 | 0 |
| Inventory Days | 26.31 | 6.21 | 16.15 | 38.83 | 104 | 0 | — | — | — | — | — | — |
| Days Payable | 25.76 | 15.8 | 120 | 7.77 | 0 | — | — | — | — | — | — | — |
| Cash Conversion Cycle | 13.16 | -2.94 | -78.29 | 49.94 | 115 | 0 | — | — | 0 | 0 | 0 | 0 |
| Working Capital Days | 46.62 | -39.44 | -97.52 | -245 | -290 | -689 | — | — | -1,095 | -6,935 | -56.15 | -122 |
| ROCE % | 14.72% | 16.32% | -7.08% | -10.54% | 1.33% | 0.33% | -16.15% | -1.79% | -7.48% | — | -2.86% | -5.06% |
Documents
1
Board Meeting Intimation for The Meeting Of The Board Of The Company Will Be Held On Thursday, March 5Th, 2026 At 5:00 P.M
26 Feb - Board meeting on 5 Mar 2026 to record POSH, monitoring agency report, compliances, and exhibition participation. 26 Feb - Board meeting on 5 Mar 2026 to record POSH, monitoring agency report, compliances, and exhibition participation.
2
Board Meeting Outcome for Outcome Of Board Meeting Held On 05.03.2026
8h - Board (05-Mar-2026) recorded POSH and monitoring agency reports; considered FY26-27 exhibitions; noted compliances and day-to-day review. 8h - Board (05-Mar-2026) recorded POSH and monitoring agency reports; considered FY26-27 exhibitions; noted compliances and day-to-day review.
3
Statement Of Deviation And Variation For Quarter Ended 31.12.2025
14 Feb - No deviation in utilisation of Rs.5,460.18 lakh IPO proceeds; Rs.2,794.57 lakh used by Dec 31, 2025. 14 Feb - No deviation in utilisation of Rs.5,460.18 lakh IPO proceeds; Rs.2,794.57 lakh used by Dec 31, 2025.
4
Statement Of Deviation And Variation For Quarter Ended 31.12.2025
13 Feb - IPO proceeds ₹5,460.18 lakh; ₹2,794.57 lakh utilised for working capital as of Dec 31, 2025. 13 Feb - IPO proceeds ₹5,460.18 lakh; ₹2,794.57 lakh utilised for working capital as of Dec 31, 2025.
5
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
13 Feb - Monitoring agency: Rs63.00cr IPO; Rs27.95cr utilized by Dec 31, 2025; no deviations. 13 Feb - Monitoring agency: Rs63.00cr IPO; Rs27.95cr utilized by Dec 31, 2025; no deviations.
Frequently Asked Questions about Amzel Ltd
Where is Amzel Ltd (509356) listed?
Amzel Ltd is listed on the Indian stock exchanges. It is listed on BSE: 509356. You can view its live share price, financials, and ratios on Tapetide.
How can I research Amzel Ltd on Tapetide?
On Tapetide, you can view Amzel Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Face Value ₹ 10